BridgeMD
New treatment option for Healthy
Official title ImmunoBoost: The Lymphatic Osteopathic Manipulative Treatment Protocol Study
ClinicalTrials.gov ID: NCT06565065
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine whether osteopathic manipulative treatment (OMT) enhances immune system readiness in healthy adults compared to exercise or sham light treatment. Specifically, the goal of this study is to assess circulating immune cells and signaling molecules in the blood in response to these various treatments.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Individuals must be 18 years or older.
- Individuals must provide informed consent.
- Individuals must be healthy with a BMI under 30, with no primary or secondary immune deficiency or autoimmune disease/must not be immunocompromised.
- Individuals must not be using or recently have used any immune-altering medications such as corticosteroids, cyclosporin, tacrolimus, and pimecrolimus
- Individuals must not have had lymphatic OMT or other physical manipulation such as acupuncture, physical therapy, chiropractic, or massage therapy in...
You likely can't join if
- Individuals are younger than 18 years of age.
- Individuals who do not provide informed consent.
- Individuals with a BMI over 30, or with primary or secondary immune deficiency or autoimmune disease or is immunocompromised.
- Individuals using or recently have used any immune-altering medications such as corticosteroids, cyclosporin, tacrolimus, and pimecrolimus
- Individuals who have had lymphatic OMT or other physical manipulation such as acupuncture, physical therapy, chiropractic, or massage therapy in the...
- Individuals who don't have the ability to receive OMT with lymphatic techniques.
See the full eligibility criteria
- Individuals must be 18 years or older.
- Individuals must provide informed consent.
- Individuals must be healthy with a BMI under 30, with no primary or secondary immune deficiency or autoimmune disease/must not be immunocompromised.
- Individuals must not be using or recently have used any immune-altering medications such as corticosteroids, cyclosporin, tacrolimus, and pimecrolimus
- Individuals must not have had lymphatic OMT or other physical manipulation such as acupuncture, physical therapy, chiropractic, or massage therapy in the previous four weeks before study enrollment.
- Individuals must have the ability to receive OMT with lymphatic techniques.
- Individuals must be able to tolerate 12 minutes of moderate physical activity.
- Individuals must not be pregnant or breastfeeding.
- Individuals must not have had a splenectomy or other spleen or oncologic surgery within the past 6 months.
- Individuals must be infection-free for the past 6 weeks before starting the study and have not received any immunizations within the past 6 weeks.
- Individuals must be willing to avoid strenuous activity at least 24 hours before each visit.
- Individuals must be willing to abstain from moderate to intense activity in the 4 hours between their 2nd blood draw and their final blood draw at each of their three visits.
- Individuals are younger than 18 years of age.
- Individuals who do not provide informed consent.
- Individuals with a BMI over 30, or with primary or secondary immune deficiency or autoimmune disease or is immunocompromised.
- Individuals using or recently have used any immune-altering medications such as corticosteroids, cyclosporin, tacrolimus, and pimecrolimus
- Individuals who have had lymphatic OMT or other physical manipulation such as acupuncture, physical therapy, chiropractic, or massage therapy in the previous four weeks before study enrollment.
- Individuals who don't have the ability to receive OMT with lymphatic techniques.
- Individuals who cannot tolerate 12 minutes of moderate physical activity.
- Individuals who are pregnant or breastfeeding.
- Individuals who have had a splenectomy or other spleen or oncologic surgery within the past 6 months.
- Individuals who have had an infection in the 6 weeks before starting the study and or have received any immunizations within the past 6 weeks.
- Individuals not willing to avoid strenuous activity at least 24 hours before each visit.
- Individuals not willing to abstain from moderate to intense activity in the 4 hours between their 2nd blood draw and their final blood draw at each of their three visits.
The study team makes the final eligibility decision.
Where it's taking place
- Pomona, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pomona, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.